{"transactions":[{"id":693798,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO","position":1,"cik":"0002058707","reported_name":"Attovia Therapeutics, Inc.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-06T21:13:56.000Z","date":"2026-08-04","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates."}],"balance_after":140000,"derivative":{"exercise_price":17,"expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-26-338430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058707/000119312526338430/ownership.xml","form_type":"4"}},{"id":693797,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO","position":1,"cik":"0002058707","reported_name":"Attovia Therapeutics, Inc.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-06T21:11:49.000Z","date":"2026-08-04","kind":"grant","planned":false,"acquired":true,"shares":538300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates."}],"balance_after":538300,"derivative":{"exercise_price":17,"expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":538300},"source":{"system":"sec-edgar","filing":"0001193125-26-338420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058707/000119312526338420/ownership.xml","form_type":"4"}}]}